SCHEMBL29407986

SCHEMBL29407986

CC(=O)N[C@H]1[C@H](OC[C@H]2OC(O)[C@H](NC(C)=O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 6/20 0.64
▸ LGALS8 O00214 1/20 0.64
▸ LGALS4 P56470 1/20 0.64
▸ MAPK1 P28482 2/20 0.53
▸ CD69 Q07108 1/20 0.49
▸ CHIA Q9BZP6 1/20 0.49
▸ LGALS1 P09382 1/20 0.48
▸ LGALS7; LGALS7B P47929 1/20 0.48
▸ AMY2A P04746 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ HPSE Q9Y251 2/20 0.46
▸ CD209 Q9NNX6 1/20 0.45
▸ LGALS9 O00182 1/20 0.45
▸ ENGASE Q8NFI3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30267118 0.99 LGALS3 (0.63) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL30185426 0.99 LGALS3 (0.63) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL13855946 0.99 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL30185411 0.99 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL13577686 0.99 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL26491880 0.99 LGALS3 (0.66) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL31139964 0.97 LGALS3 (0.61) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL30185407 0.97 LGALS3 (0.61) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL29872627 0.96 LGALS3 (0.64) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL29532287 0.95 LGALS3 (0.61) LGALS3LGALS8LGALS4MAPK1CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260004881-A1 METHODS AND SYSTEMS FOR CHARACTERIZING PROTEINS NAUTILUS SUBSIDIARY INC (US) 2026-01-01 — — US disclosed
US-20250391496-A1 DECODING APPROACHES FOR PROTEIN IDENTIFICATION NAUTILUS SUBSIDIARY INC (US) 2025-12-25 — — US disclosed
US-20250292870-A1 METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION NAUTILUS SUBSIDIARY INC (US) 2025-09-18 — — US disclosed
US-12148509-B2 Decoding approaches for protein identification NAUTILUS SUBSIDIARY, INC. (US) 2024-11-19 — — US disclosed
EP-3701066-B1 METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION NAUTILUS SUBSIDIARY INC (US) 2024-10-16 — — EP disclosed
EP-4372383-A2 METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION Nautilus Subsidiary, Inc. (US) 2024-05-22 — — EP disclosed
EP-4370664-A1 LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES Inbiose N.V. (BE) 2024-05-22 — — EP disclosed
US-11721412-B2 Methods for identifying a protein in a sample of unknown proteins NAUTILUS SUBSIDIARY, INC. (US) 2023-08-08 — — US disclosed
US-20230117795-A1 DECODING APPROACHES FOR PROTEIN IDENTIFICATION NAUTILUS BIOTECHNOLOGY, INC. 2023-04-20 — — US disclosed
WO-2023285650-A1 LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES INBIOSE N.V. (BE) 2023-01-19 — — WO disclosed
US-11545234-B2 Decoding approaches for protein identification NAUTILUS BIOTECHNOLOGY, INC. (US) 2023-01-03 — — US disclosed
US-11282586-B2 Decoding approaches for protein identification NAUTILUS BIOTECHNOLOGY, INC. (US) 2022-03-22 — — US disclosed
US-11282585-B2 Decoding approaches for protein identification NAUTILUS BIOTECHNOLOGY, INC. (US) 2022-03-22 — — US disclosed
US-20220068431-A1 DECODING APPROACHES FOR PROTEIN IDENTIFICATION NAUTILUS SUBSIDIARY, INC. 2022-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260004881-A1 METHODS AND SYSTEMS FOR CHARACTERIZING PROTEINS PTMS, SRMS, CHAMP1 LGALS3 1388/4885LGALS8 1371/4885LGALS4 1259/4885
US-20250391496-A1 DECODING APPROACHES FOR PROTEIN IDENTIFICATION CHAMP1, PTMS, PSMG3 LGALS3 1869/4885LGALS8 2109/4885LGALS4 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback